Mesoblast Files Director Interest & New Issue Notices
Ticker: MEOBF · Form: 6-K · Filed: Oct 29, 2025 · CIK: 1345099
| Field | Detail |
|---|---|
| Company | Mesoblast LTD (MEOBF) |
| Form Type | 6-K |
| Filed Date | Oct 29, 2025 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: director-filing, new-issue, ASX
Related Tickers: MESO
TL;DR
MESO filed director interest and new issue docs with ASX - check for insider moves.
AI Summary
On October 28, 2025, Mesoblast Limited filed a new issue announcement and a change of director's interest notice (Appendix 3Y) with the Australian Securities Exchange. The company is incorporated in Australia and its CEO is Silviu Itescu.
Why It Matters
This filing indicates potential changes in director holdings and new share issuances, which could signal internal confidence or strategic financing activities.
Risk Assessment
Risk Level: medium — Filings related to director interests and new share issuances can signal significant internal activity or financing, requiring closer scrutiny.
Key Players & Entities
- Mesoblast Limited (company) — Registrant
- Silviu Itescu (person) — Chief Executive Officer and Executive Director
- October 28, 2025 (date) — Filing date
- Australian Securities Exchange (company) — Exchange where filings were made
FAQ
What specific details were included in the new issue announcement?
The filing states that a new issue announcement was made, but the specific details of the issue are not provided in this summary document.
What change was reported in the director's interest notice (Appendix 3Y)?
The filing mentions a 'change of director's interest notice (Appendix 3Y)' was filed, but the nature of the change is not detailed here.
Who is the CEO of Mesoblast Limited?
Silviu Itescu is the Chief Executive Officer and Executive Director of Mesoblast Limited.
On what date were these filings made?
The filings were made on October 28, 2025.
Where is Mesoblast Limited incorporated?
Mesoblast Limited is incorporated in Australia.
Filing Stats: 271 words · 1 min read · ~1 pages · Grade level 15.9 · Accepted 2025-10-28 21:04:09
Filing Documents
- form6-kxpressreleasecoverf.htm (6-K) — 17KB
- exhibit991appendix3y3g.htm (EX-99.1) — 4KB
- exhibit992appendix3y3g.htm (EX-99.2) — 7KB
- exhibit991appendix3y3g001.jpg (GRAPHIC) — 149KB
- exhibit991appendix3y3g002.jpg (GRAPHIC) — 120KB
- exhibit992appendix3y3g001.jpg (GRAPHIC) — 72KB
- exhibit992appendix3y3g002.jpg (GRAPHIC) — 58KB
- exhibit992appendix3y3g003.jpg (GRAPHIC) — 59KB
- exhibit992appendix3y3g004.jpg (GRAPHIC) — 152KB
- exhibit992appendix3y3g005.jpg (GRAPHIC) — 37KB
- exhibit992appendix3y3g006.jpg (GRAPHIC) — 93KB
- 0001345099-25-000092.txt ( ) — 1048KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized. Mesoblast Limited s Niva Sivakumar Niva Sivakumar Company Secretary Dated October 29, 2025 INDEX TO EXHIBITS Item 99.1 Appendix 3Y of Mesoblast Ltd, dated October 28, 2025. 99.2 Appendix 3G of Mesoblast Ltd, dated October 28, 2025.